1454 / 1498
Gavrilovic, I. T. et al. J Clin Oncol; 24:4570-4574 2006
Overall survival (OS) and progression-free survival (PFS) for the entire cohort
Median follow-up of 115 months
Median OS: 51 months
Median time to progression: 129 months